U.S. General Anesthesia Drugs Market (2011 - 2015) - Market Entry Strategy

1
MarketsandMarkets Presents
Anesthesia Drugs Market in U.S. worth 7 Billion
by 2015
http//www.marketsandmarkets.com/Market-Reports/an
esthesia-drugs-ketamine-market-713.html
2
The Anesthesia Drugs Market (2011 - 2015) - U.S.
Market Entry Study analyzes and studies the U.S.
market for intravenous anesthesia drugs with
special focus on ketamine, distribution structure
of anesthesia drugs in U.S., potential buyers,
export import system for controlled substances
in U.S. and U.S. market entry strategy. Browse
market data tables and in-depth TOC on this
reporthttp//www.marketsandmarkets.com/Market-Rep
orts/anesthesia-drugs-ketamine-market-713.html Ea
rly buyers will receive 10 customization on this
report.
3
This report studies the U.S. Ketamine market over
the period of 2007-2015. Ketamine market is
expected to grow at a moderate rate from 2011 to
2016. Anesthesia is a condition in which
sensation is totally or partially blocked. This
enables the patients to undergo medical
procedures and surgery. Based on the applications
(type of surgery or medical procedure) anesthetic
drugs are broadly categorized into two types
i.e. local anesthetic drugs and general
anesthetic drugs. Local anesthesia is a condition
when sensation within a specific body part in
inhibited, where as general anesthesia results in
loss of consciousness and sensation. General
anesthesia includes blockage of pain, awareness,
and memory. Advantages offered by general
anesthesia includes - rapid onset of anesthesia,
full control of the body processes (airway,
respiratory and circulatory system), used in
surgeries with unpredictable duration of surgery,
no memory of the surgery, allows complete
motionlessness over prolonged duration of the
surgery and it permits simultaneous operation on
different body parts.
4
General anesthesia drugs involve inhalation and
intravenous anesthesia drugs. Report is specially
focused on general intravenous anesthesia drugs
category. Drugs such as propofol, midazolam
diazepam, fospropofol disodium, sodium pentothal,
ketamine, methohexital sodium, pentobarbital,
etomidate, and fentanyl are studied. The U.S.
general anesthesia market size was approximately
2 billion in 2011 and is expected to grow at a
moderate rate, with a CAGR of approximately 4
from 2011 to 2015. In addition, intravenous
anesthetic drugs accounted for the largest share
65 of the U.S. general anesthetics drugs
market in 2011. Ketamine is an anesthetic drug
mainly used for initiation and maintenance of
general anesthesia in humans. It belongs to NMDA
receptor antagonist class, which includes
molecules that prevent the action of the N-methyl
D-aspartate (NMDA) receptor. Factors such as
increase in aging population, rising
cardiovascular, and respiratory system related
diseases and rising number of emergency surgeries
will help in maintaining stable growth in the
ketamine market revenue in the next five years
along with the overall growth of the U.S. general
intravenous anesthesia market.
5
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/an
esthesia-drugs-ketamine-market-713.html
6
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets